Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines
manilatimes.net · 2026-09-14
Sanofi and Cheplapharmto create new strategic partnership in mature medicines
TickrTrends take: Sanofi's strategic partnership with Cheplapharm in mature medicines represents a move to optimize its portfolio in a segment typically characterized by stable but modest growth profiles. Given TickrTrends' current undervalued assessment, investors focused on valuation should monitor whether this partnership generates meaningful cost efficiencies or revenue stabilization that could support the company's financial metrics. The mature medicines market offers predictable cash flows, which aligns with the type of fundamentals that often underpin value-oriented positioning in the Healthcare sector.
Read the full story at manilatimes.net →
Is SNY undervalued? See TickrTrends' fair value analysis →